Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Interest & Investment Income: 2013-2024

Historic Interest & Investment Income for ProQR Therapeutics N.V (PRQR) over the last 12 years, with Dec 2024 value amounting to $3.5 million.

  • ProQR Therapeutics N.V's Interest & Investment Income fell 36.45% to $327,335 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 28.21%. This contributed to the annual value of $3.5 million for FY2024, which is 23.86% up from last year.
  • ProQR Therapeutics N.V's Interest & Investment Income amounted to $3.5 million in FY2024, which was up 23.86% from $2.8 million recorded in FY2023.
  • In the past 5 years, ProQR Therapeutics N.V's Interest & Investment Income ranged from a high of $5.0 million in FY2022 and a low of $357,375 during FY2020.
  • Over the past 3 years, ProQR Therapeutics N.V's median Interest & Investment Income value was $3.5 million (recorded in 2024), while the average stood at $3.7 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first slumped by 78.51% in 2020, then soared by 402.00% in 2021.
  • Yearly analysis of 5 years shows ProQR Therapeutics N.V's Interest & Investment Income stood at $357,375 in 2020, then soared by 402.00% to $1.8 million in 2021, then surged by 176.55% to $5.0 million in 2022, then tumbled by 43.47% to $2.8 million in 2023, then climbed by 23.86% to $3.5 million in 2024.